TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,723.99+0.43%Nasdaq 10029,573.57+0.15%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.70−0.18%NYSE:TSM$426.97+1.61%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,124.07−0.40%Brent$108.61−0.56%BTC$82,314.58+0.58%ETH$2,431.18+1.08%DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,723.99+0.43%Nasdaq 10029,573.57+0.15%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.70−0.18%NYSE:TSM$426.97+1.61%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,124.07−0.40%Brent$108.61−0.56%BTC$82,314.58+0.58%ETH$2,431.18+1.08%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Corbus Pharmaceuticals Holdings Inc · Overview · TradingHolo

Markets › United States › NAS › CRBP

C

Corbus Pharmaceuticals Holdings Inc

NAS:CRBPHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$4.52+4.39%At closeAt close · Sat 17 Oct · ≈ AED 16.60 · Market cap — · Next earnings Tue 10 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+4.4%

1M

−37.7%

3M

−49.2%

6M

−57.3%

1Y

−74.2%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

CRBP +4.39% today

✦ This week in three lines

No written digest yet for CRBP. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector—

Price / Book vs sector—

Price / Sales vs sector—

Price / Free cash flow vs sector—

Forecasts

10 buy0 hold0 sell10 analysts

Average target$33.00 +630.1%

Analysts1

EPS surprises, last 84 beats

Dividends

Corbus Pharmaceuticals Holdings Inc has not paid a dividend in the last five years.

Latest news

All CRBP news →

TRCorbus Pharmaceuticals updates corporate presentation, highlights CRB-701 OPSCC progress and CRB-913 obesity data

TradingView · 5 d ago

GLCorbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

GlobeNewswire · 21 d ago

GLCorbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

globenewswire · 36 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)—

P/E—

Dividend yield—

52-week range$4.22 – $20.56

Avg volume (20d)859,777

Shares outstanding19,341,300

Beta2.60

Short interest17.6% of float

Next earningsTue 10 Nov

Radar Score

—

Value—

Quality—

Momentum—

Income—

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601,…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%